Collectively, our data revealed that PRP19 plays a critical role in B cell immune dysfunction via mediating DDX5 and CXCL12 levels, and is clinically associated with poor prognosis of HCC (Figure 8H). This evidence concerns the gene PRPF19 and hepatocellular carcinoma.